Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial
Cahn, Pedro, Dr, Andrade-Villanueva, Jaime, MD, Arribas, José R, MD, Gatell, José M, MD, Lama, Javier R, MD, Norton, Michael, MD, Patterson, Patricia, MD, Madero, Juan Sierra, MD, Sued, Omar, MD, Figueroa, Maria Inés, MD, Rolon, Maria José, MD
Published in The Lancet infectious diseases (01.07.2014)
Published in The Lancet infectious diseases (01.07.2014)
Get full text
Journal Article